It is a trading private limited company based in New Delhi, Delhi, India, established in 2014.
2014 | New Delhi, Delhi, India | ActiveMediprio Pharmacueticals Private Limited, a active private limited company, was established on 29 May 2014 in New Delhi, Delhi, India. Engaging in other wholesale within the trade sector, it holds CIN: U74140DL2014PTC267688. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Anuj Kumar (Director), Sonal Khurana (Director). Past directors included Roshan Lal Khurana, Kamal Kishore Pali, Satyam Jain. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at House Number -91, First Floor Rajindra Market, Tis Hazari, New Delhi, Delhi, 110054.
U74140DL2014PTC267688
267688
29 May 2014
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Mediprio Pharmacueticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anuj Kumar | Director | 29 May 2014 | Current |
| Sonal Khurana | Director | 29 May 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Jul 2014 | Past |
| Pramod Abcsdd | Director | 14 Feb 2022 | Past |
| Pramod Abcsdd | Director | 07 Nov 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mediprio Pharmacueticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Mediprio Pharmacueticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Mediprio Pharmacueticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mediprio Pharmacueticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediprio Pharmacueticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Mediprio Pharmacueticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Mediprio Pharmacueticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
Progress on Anuj Kumar was appointed as a Director was appointed as a Director on 29 May 2014 & has been associated with this company since 11 years 6 months . was documented.
Sonal Khurana was appointed as a Director was appointed as a Director on 29 May 2014 & has been associated with this company since 11 years 6 months . was recorded as a recent event.
Mediprio Pharmacueticals Private Limited was registered on 29 May 2014 with Roc Delhi & aged 11 years 6 months as per MCA records. was recorded as a recent event.
The CIN of Mediprio Pharmacueticals Private Limited is U74140DL2014PTC267688.
Mediprio Pharmacueticals Private Limited is headquartered at House Number -91, First Floor Rajindra Market, Tis Hazari, New Delhi, Delhi, 110054.
Mediprio Pharmacueticals Private Limited was incorporated on 29 May 2014.
The current directors of Mediprio Pharmacueticals Private Limited are
The primary industry of Mediprio Pharmacueticals Private Limited is Trade.
Mediprio Pharmacueticals Private Limited is unlisted.
The authorized capital of Mediprio Pharmacueticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Mediprio Pharmacueticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX